142 related articles for article (PubMed ID: 28189378)
1. Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma.
Lum EL; Huang E; Bunnapradist S; Pham T; Danovitch G
Am J Kidney Dis; 2017 May; 69(5):701-704. PubMed ID: 28189378
[TBL] [Abstract][Full Text] [Related]
2. Severe Renal Allograft Rejection Resulting from Lenalidomide Therapy for Multiple Myeloma: Case Report.
Walavalkar V; Adey DB; Laszik ZG; Jen KY
Transplant Proc; 2018 Apr; 50(3):873-876. PubMed ID: 29661456
[TBL] [Abstract][Full Text] [Related]
3. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
Kutzler HL; Ye X; Rochon C; Martin ST
Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
[TBL] [Abstract][Full Text] [Related]
4. Fatal cardiac and renal allograft rejection with lenalidomide therapy for light-chain amyloidosis.
Meyers DE; Adu-Gyamfi B; Segura AM; Buja LM; Mallidi HR; Frazier OH; Rice L
Am J Transplant; 2013 Oct; 13(10):2730-3. PubMed ID: 23914832
[TBL] [Abstract][Full Text] [Related]
5. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
[TBL] [Abstract][Full Text] [Related]
6. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
Guo YW; Gu HY; Abassa KK; Lin XY; Wei XQ
World J Gastroenterol; 2016 Jun; 22(24):5616-22. PubMed ID: 27350740
[TBL] [Abstract][Full Text] [Related]
8. Acute mixed cellular and humoral rejection of renal allograft with leucopenia.
Agarwal DK; Hota JK; Malhotra V
J Assoc Physicians India; 2011 Aug; 59():524-6. PubMed ID: 21887916
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
10. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide and lenalidomide in multiple myeloma.
Mazumder A; Jagannath S
Best Pract Res Clin Haematol; 2006; 19(4):769-80. PubMed ID: 16997182
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.
García-Muñoz R; Robles-de-Castro D; Muñoz-Rodríguez A; Rabasa P
Leuk Lymphoma; 2013 Dec; 54(12):2753-5. PubMed ID: 23488662
[No Abstract] [Full Text] [Related]
13. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
[TBL] [Abstract][Full Text] [Related]
14. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.
Höcker B; Weber LT; Bunchman T; Rashford M; Tönshoff B;
Pediatr Transplant; 2005 Aug; 9(4):504-11. PubMed ID: 16048604
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch.
Huh KH; Kim SI; Joo DJ; Ju MK; Chang HK; Kim HJ; Kim YS; Kim MS
Nephron Clin Pract; 2009; 111(1):c49-54. PubMed ID: 19052470
[TBL] [Abstract][Full Text] [Related]
17. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
[TBL] [Abstract][Full Text] [Related]
18. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Hirose R; Stock P
Arch Surg; 2003 Oct; 138(10):1121-5; discussion 1125-6. PubMed ID: 14557130
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients.
Palanisamy AP; Al Manasra AR; Pilch NA; Dowden JE; Nadig SN; McGillicuddy JW; Baliga PK; Chavin KD; Taber DJ
Clin Transplant; 2015 Mar; 29(3):222-6. PubMed ID: 25557762
[TBL] [Abstract][Full Text] [Related]
20. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
